Douglas E. Feldman

1.9k total citations
20 papers, 1.3k citations indexed

About

Douglas E. Feldman is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Douglas E. Feldman has authored 20 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Douglas E. Feldman's work include Endoplasmic Reticulum Stress and Disease (5 papers), RNA modifications and cancer (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Douglas E. Feldman is often cited by papers focused on Endoplasmic Reticulum Stress and Disease (5 papers), RNA modifications and cancer (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Douglas E. Feldman collaborates with scholars based in United States, Cuba and India. Douglas E. Feldman's co-authors include Judith Frydman, Albert C. Koong, Vibha Chauhan, Raúl G. Ferreyra, Vanitha Thulasiraman, Keigo Machida, Chia‐Lin Chen, Vasu Punj, Yibu Chen and Hidekazu Tsukamoto and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Molecular Cell.

In The Last Decade

Douglas E. Feldman

20 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Douglas E. Feldman United States 16 957 386 246 235 200 20 1.3k
Andrew P. VanDemark United States 23 1.7k 1.7× 224 0.6× 193 0.8× 151 0.6× 188 0.9× 42 2.0k
Elton Zeqiraj United Kingdom 19 1.1k 1.1× 242 0.6× 121 0.5× 145 0.6× 198 1.0× 27 1.5k
Hsiangling Teo Singapore 14 895 0.9× 463 1.2× 196 0.8× 98 0.4× 152 0.8× 19 1.3k
Neysan Donnelly Germany 10 892 0.9× 548 1.4× 167 0.7× 205 0.9× 124 0.6× 11 1.3k
Ruud H. Wijdeven Netherlands 16 686 0.7× 414 1.1× 94 0.4× 245 1.0× 180 0.9× 31 1.3k
Maria Hackett United States 7 1.7k 1.7× 218 0.6× 236 1.0× 214 0.9× 221 1.1× 8 2.0k
Elah Pick Israel 22 1.2k 1.2× 327 0.8× 93 0.4× 179 0.8× 197 1.0× 42 1.7k
Babak Oskouian United States 19 1.1k 1.2× 346 0.9× 103 0.4× 110 0.5× 66 0.3× 26 1.3k
Maximiliane Hilger Germany 11 1.2k 1.3× 257 0.7× 76 0.3× 119 0.5× 92 0.5× 11 1.6k
David R. Loiselle United States 21 927 1.0× 174 0.5× 245 1.0× 66 0.3× 111 0.6× 31 1.3k

Countries citing papers authored by Douglas E. Feldman

Since Specialization
Citations

This map shows the geographic impact of Douglas E. Feldman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas E. Feldman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas E. Feldman more than expected).

Fields of papers citing papers by Douglas E. Feldman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas E. Feldman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas E. Feldman. The network helps show where Douglas E. Feldman may publish in the future.

Co-authorship network of co-authors of Douglas E. Feldman

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas E. Feldman. A scholar is included among the top collaborators of Douglas E. Feldman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas E. Feldman. Douglas E. Feldman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yeh, Da‐Wei, Xuyao Zhao, Hifzur R. Siddique, et al.. (2023). MSI2 promotes translation of multiple IRES-containing oncogenes and virus to induce self-renewal of tumor initiating stem-like cells. Cell Death Discovery. 9(1). 141–141. 6 indexed citations
2.
Ho, Pei‐Yin, et al.. (2023). Bacteriophage antidefense genes that neutralize TIR and STING immune responses. Cell Reports. 42(4). 112305–112305. 21 indexed citations
3.
Shukla, Vipul, Levon Halabelian, Daniela Samaniego‐Castruita, et al.. (2019). HMCES Functions in the Alternative End-Joining Pathway of the DNA DSB Repair during Class Switch Recombination in B Cells. Molecular Cell. 77(2). 384–394.e4. 36 indexed citations
4.
Kweon, Soo-Mi, et al.. (2019). An Adversarial DNA N6-Methyladenine-Sensor Network Preserves Polycomb Silencing. Molecular Cell. 74(6). 1138–1147.e6. 113 indexed citations
5.
Siddique, Hifzur R., et al.. (2017). Abstract 2542: MSI2 binds LncRNAs and promotes self-renewal and oncogenesis through MYC expression. Cancer Research. 77(13_Supplement). 2542–2542. 2 indexed citations
6.
Kweon, Soo-Mi, Bing Zhu, Yibu Chen, et al.. (2017). Erasure of Tet-Oxidized 5-Methylcytosine by a SRAP Nuclease. Cell Reports. 21(2). 482–494. 22 indexed citations
7.
Kumar, Dinesh Babu Uthaya, Chia‐Lin Chen, Jianchang Liu, et al.. (2015). TLR4 Signaling via NANOG Cooperates With STAT3 to Activate Twist1 and Promote Formation of Tumor-Initiating Stem-Like Cells in Livers of Mice. Gastroenterology. 150(3). 707–719. 90 indexed citations
8.
Siddique, Hifzur R., Douglas E. Feldman, Chia‐Lin Chen, et al.. (2015). NUMB phosphorylation destabilizes p53 and promotes self‐renewal of tumor‐initiating cells by a NANOG‐dependent mechanism in liver cancer. Hepatology. 62(5). 1466–1479. 54 indexed citations
9.
Machida, Keigo, Douglas E. Feldman, & Hidekazu Tsukamoto. (2014). TLR4-Dependent Tumor-Initiating Stem Cell-Like Cells (TICs) in Alcohol-Associated Hepatocellular Carcinogenesis. Advances in experimental medicine and biology. 815. 131–144. 18 indexed citations
10.
Feldman, Douglas E., Chia‐Lin Chen, Vasu Punj, & Keigo Machida. (2013). The TBC1D15 Oncoprotein Controls Stem Cell Self-Renewal through Destabilization of the Numb-p53 Complex. PLoS ONE. 8(2). e57312–e57312. 21 indexed citations
11.
Machida, Keigo, Chia‐Lin Chen, Douglas E. Feldman, et al.. (2012). Cancer stem cells generated by alcohol, diabetes, and hepatitis C virus. Journal of Gastroenterology and Hepatology. 27(s2). 19–22. 38 indexed citations
12.
Feldman, Douglas E., Chia‐Lin Chen, Vasu Punj, Hidekazu Tsukamoto, & Keigo Machida. (2011). Pluripotency factor-mediated expression of the leptin receptor (OB-R) links obesity to oncogenesis through tumor-initiating stem cells. Proceedings of the National Academy of Sciences. 109(3). 829–834. 70 indexed citations
13.
Koumenis, Constantinos, Meixia Bi, Jiangbin Ye, Douglas E. Feldman, & Albert C. Koong. (2007). Hypoxia and the Unfolded Protein Response. Methods in enzymology on CD-ROM/Methods in enzymology. 435. 275–293. 29 indexed citations
14.
Feldman, Douglas E. & Albert C. Koong. (2007). Irestatin, a potent inhibitor of IRE1α and the unfolded protein response, is a hypoxia-selective cytotoxin and impairs tumor growth. Journal of Clinical Oncology. 25(18_suppl). 3514–3514. 12 indexed citations
15.
Feldman, Douglas E. & Albert C. Koong. (2007). Identification of Irestatins: A Novel Class of Hypoxia Targeted Cancer Therapeutics. International Journal of Radiation Oncology*Biology*Physics. 69(3). S149–S150. 2 indexed citations
16.
Feldman, Douglas E., Vibha Chauhan, & Albert C. Koong. (2005). The Unfolded Protein Response: A Novel Component of the Hypoxic Stress Response in Tumors. Molecular Cancer Research. 3(11). 597–605. 247 indexed citations
17.
Chen, Yijun, Douglas E. Feldman, Changchun Deng, et al.. (2005). Identification of Mitogen-Activated Protein Kinase Signaling Pathways That Confer Resistance to Endoplasmic Reticulum Stress in Saccharomyces cerevisiae. Molecular Cancer Research. 3(12). 669–677. 109 indexed citations
18.
Feldman, Douglas E., Christoph Spiess, Daniel E. Howard, & Judith Frydman. (2003). Tumorigenic Mutations in VHL Disrupt Folding In Vivo by Interfering with Chaperonin Binding. Molecular Cell. 12(5). 1213–1224. 89 indexed citations
19.
Feldman, Douglas E. & Judith Frydman. (2000). Protein folding in vivo: the importance of molecular chaperones. Current Opinion in Structural Biology. 10(1). 26–33. 161 indexed citations
20.
Feldman, Douglas E., Vanitha Thulasiraman, Raúl G. Ferreyra, & Judith Frydman. (1999). Formation of the VHL–Elongin BC Tumor Suppressor Complex Is Mediated by the Chaperonin TRiC. Molecular Cell. 4(6). 1051–1061. 196 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew P. VanDemark Breakdown of academic impact, for papers by Elton Zeqiraj Breakdown of academic impact, for papers by Hsiangling Teo Breakdown of academic impact, for papers by Neysan Donnelly Breakdown of academic impact, for papers by Ruud H. Wijdeven Breakdown of academic impact, for papers by Maria Hackett Breakdown of academic impact, for papers by Elah Pick Breakdown of academic impact, for papers by Babak Oskouian Breakdown of academic impact, for papers by Maximiliane Hilger Breakdown of academic impact, for papers by David R. Loiselle
Rankless by CCL
2026